drugset / Trial / NCT01097577

A Comparison of Pregabalin (Lyrica®) to Placebo in Pain Relief After Photorefractive Keratectomy (PRK) Surgery

NCT01097577 ↗

Completed 130 enrolled 59th Medical Wing
RandomizedParallel-groupTriple-blindTreatment

Summary

The purpose of this study is to compare the efficacy of pregabalin to placebo for postoperative pain control after photorefractive keratectomy.

Timeline

Start
2010-03
Primary completion
2010-06
Completion
2010-06

Outcome

Missed primary endpoint

registry analysis (superiority test); Pregabalin vs Lactose Capsule; p = 0.180; ANOVA NCT01097577 ↗

paper There was no statistically significant difference in the primary outcome of 10% improvement in subjective pain scores between the treatment and placebo groups PMID 24914779 ↗

Drugs

EvaluationDrugModalityDoseRoute
Subject Pregabalin Small molecule 75 mg Oral

Indications

No indication recorded.